Publication Name	World Journal of Obstetrics and Gynecology
Manuscript ID	17522
Country	United States

Received	2015-03-12 10:14
Peer-Review Started	2015-03-16 20:19
To Make the First Decision	2015-04-10 17:44
Return for Revision	2015-04-17 08:56
Revised	2015-05-16 02:44
Second Decision	2015-07-06 08:37
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-07-17 14:30
Articles in Press	2015-07-17 14:30
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-07-29 17:28
Publish the Manuscript Online	2015-08-17 15:47

ISSN	2218-6220 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Obstetrics & Gynecology
Manuscript Type	Editorial
Article Title	Avoiding misdiagnosing an early intrauterine pregnancy as an ectopic pregnancy
Manuscript Source	Invited Manuscript
All Author List	Donald L Fylstra
Funding Agency and Grant Number
Corresponding Author	Donald L Fylstra, MD, Professor, Department of Obstetrics and Gynecology, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, United States. fylstrad@musc.edu
Key Words	Ectopic pregnancy; Ultrasound; Human chorionic gonadotropin; Methotrexate
Core Tip	In women at risk for an ectopic pregnancy, every effort should be made to exclude the presence of an intrauterine pregnancy before embarking on an irreversible treatment course. Methotrexate is an antimetabolite that inhibits DNA synthesis and repair and cell replication. It is administered to ostensible destroy a pregnancy, especially ectopic pregnancies. When administered to an intrauterine pregnancy, embryonic death and missed abortion is the most common result, but early embryos that survive this exposure are likely to have multiple anomalies.
Publish Date	2015-08-17 15:47
Citation	Fylstra DL. Avoiding misdiagnosing an early intrauterine pregnancy as an ectopic pregnancy. World J Obstet Gynecol 2015; 4(3): 58-63
URL	http://www.wjgnet.com/2218-6220/full/v4/i3/58.htm
DOI	http://dx.doi.org/10.5317/wjog.v4.i3.58

Full Article (PDF)	WJOG-4-58.pdf
Full Article (Word)	WJOG-4-58.doc
Manuscript File	17522-Review.docx
Answering Reviewers	17522-Answering reviewers.pdf
Audio Core Tip	17522-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	17522-Conflict-of-interest statement.pdf
Copyright License Agreement	17522-Copyright assignment.pdf
Peer-review Report	17522-Peer-review(s).pdf
Scientific Misconduct Check	17522-Scientific misconduct check.pdf
Scientific Editor Work List	17522-Scientific editor work list.pdf